Anti-Inflammatory Therapeutics Market Surges Past $106 Billion by 2020

Rising demand for anti-inflammatory drugs propels market growth, led by biologics and expanding Asia-Pacific region.

WILMINGTON, DELAWARE, UNITED STATES, April 30, 2024 /EINPresswire.com/ -- Anti-Inflammatory Therapeutics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $106.1 billion by 2020, registering a CAGR of 5.9% during the period 2015-2020. The anti-inflammatory biologic segment held 3/5th of overall market in 2014. The Asia Pacific market would exhibit the highest CAGR of 8.5% during the forecast period.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟏𝟗𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/request-sample/286

Inflammation is the mechanism of innate immunity, which eliminates the cause of injury. Sometimes, the body's defense system inappropriately triggers inflammation against its own cells, resulting in inflammatory autoimmune diseases. Reducing inflammation is one of the primary therapeutic strategies in acute as well as chronic diseases such as arthritis, psoriasis, and asthma. The rising incidences of autoimmune and respiratory conditions, extensive drug development pipeline, and increasing popularity of anti-inflammatory drugs with lesser side effects are the key factors driving the growth of the global anti-inflammatory therapeutics market. In addition, growing awareness about anti-inflammatory therapeutics and government initiatives, in the Asia pacific and LAMEA would further boost the market growth. However, adverse effects associated with long term consumption of drugs, namely NSAIDs and Corticosteroids would limit the market growth to a certain extent.

The Anti-Inflammatory Therapeutics Market Report by Allied Market Research presents a comprehensive overview of the industry, highlighting significant growth projections and key market dynamics. The global anti-inflammatory therapeutics market is forecasted to reach $106.1 billion by 2020, with a Compound Annual Growth Rate (CAGR) of 5.9% during the period 2015-2020. Segment analysis reveals that the anti-inflammatory biologic segment accounted for 3/5th of the overall market in 2014, with arthritis indication being the major revenue-generating segment, followed by respiratory diseases. The psoriasis segment is projected to grow the fastest at a CAGR of 8.1%.

Regionally, North America currently leads the market, contributing about half of the global revenue, with the U.S. dominating the North America market. However, the Asia-Pacific region is expected to exhibit the highest CAGR of 8.5% during the forecast period. Factors driving market growth include rising incidences of autoimmune and respiratory conditions, an extensive drug development pipeline, increasing popularity of anti-inflammatory drugs with fewer side effects, and growing awareness about anti-inflammatory therapeutics. However, adverse effects associated with long-term consumption of drugs, particularly NSAIDs and Corticosteroids, may limit market growth to some extent.

𝐆𝐞𝐭 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐢𝐦𝐩𝐚𝐜𝐭 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐧 𝐭𝐡𝐞 𝐀𝐧𝐭𝐢-𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 @ https://www.alliedmarketresearch.com/request-for-customization/286

Trends in developed vs. developing economies show that developed economies like North America and Europe prefer branded drugs over generics, whereas developing economies exhibit a reverse trend. Companies in the market are focusing on drug pipeline development and product launches to overcome patent expiries of existing drugs and gain additional market share. Major players include Pfizer Inc., Abbvie Inc., Johnson & Johnson, GlaxoSmithKline, Merck & CO., Inc., Novartis, F. Hoffman La Roche AG, Eli Lilly and Company, AstraZeneca PLC, and Amgen.

The report provides valuable insights for stakeholders to understand the current market scenario, identify growth opportunities, and formulate effective strategies to navigate the dynamic landscape of the anti-inflammatory therapeutics market.

𝐅𝐫𝐞𝐪𝐮𝐞𝐧𝐭𝐥𝐲 𝐀𝐬𝐤𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬?

𝐐𝟏. 𝐖𝐡𝐚𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐭𝐨𝐭𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟 𝐀𝐧𝐭𝐢-𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 ?
𝐐𝟐. 𝐖𝐡𝐚𝐭 𝐰𝐨𝐮𝐥𝐝 𝐛𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭?
𝐐𝟑. 𝐖𝐡𝐚𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟𝐀𝐧𝐭𝐢-𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝟐𝟎𝟐𝟎?
𝐐𝟒. 𝐖𝐡𝐢𝐜𝐡 𝐢𝐬 𝐛𝐚𝐬𝐞 𝐲𝐞𝐚𝐫 𝐜𝐚𝐥𝐜𝐮𝐥𝐚𝐭𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞𝐀𝐧𝐭𝐢-𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭?
𝐐𝟓. 𝐃𝐨𝐞𝐬 𝐭𝐡𝐞 𝐀𝐧𝐭𝐢-𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐜𝐨𝐦𝐩𝐚𝐧𝐲 𝐢𝐬 𝐩𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭?
𝐐𝟔. 𝐖𝐡𝐢𝐜𝐡 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐭𝐨𝐩 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐡𝐨𝐥𝐝 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐡𝐚𝐫𝐞 𝐢𝐧 𝐀𝐧𝐭𝐢-𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐌𝐚𝐫𝐤𝐞𝐭?
𝐐𝟕. 𝐃𝐨𝐞𝐬 𝐭𝐡𝐞 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥/𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐍𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐕𝐚𝐥𝐮𝐞 𝐂𝐡𝐚𝐢𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬?
𝐐𝟖. 𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐭𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐀𝐧𝐭𝐢-𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭?

𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐭𝐨 𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐭𝐡𝐞 𝐃𝐚𝐭𝐚 𝐰𝐢𝐭𝐡 𝐀𝐜𝐭𝐢𝐨𝐧𝐚𝐛𝐥𝐞 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲 & 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐡𝐞𝐫𝐞 @ https://www.alliedmarketresearch.com/purchase-enquiry/286

𝐓𝐀𝐁𝐋𝐄 𝐎𝐅 𝐂𝐎𝐍𝐓𝐄𝐍𝐓

𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝟏 : 𝐈𝐍𝐓𝐑𝐎𝐃𝐔𝐂𝐓𝐈𝐎𝐍
𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝟐 : 𝐄𝐗𝐄𝐂𝐔𝐓𝐈𝐕𝐄 𝐒𝐔𝐌𝐌𝐀𝐑𝐘
𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝟑 : 𝐌𝐀𝐑𝐊𝐄𝐓 𝐎𝐕𝐄𝐑𝐕𝐈𝐄𝐖
𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝟒 : 𝐆𝐋𝐎𝐁𝐀𝐋 𝐀𝐍𝐓𝐈 -𝐈𝐍𝐅𝐋𝐀𝐌𝐌𝐀𝐓𝐎𝐑𝐘 𝐓𝐇𝐄𝐑𝐀𝐏𝐄𝐔𝐓𝐈𝐂𝐒 𝐌𝐀𝐑𝐊𝐄𝐓 𝐁𝐘 𝐃𝐑𝐔𝐆 𝐂𝐋𝐀𝐒𝐒
𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝟓 : 𝐆𝐋𝐎𝐁𝐀𝐋 𝐀𝐍𝐓𝐈-𝐈𝐍𝐅𝐋𝐀𝐌𝐌𝐀𝐓𝐎𝐑𝐘 𝐇𝐄𝐑𝐀𝐏𝐄𝐔𝐓𝐈𝐂𝐒 𝐌𝐀𝐑𝐊𝐄𝐓 𝐁𝐘 𝐈𝐍𝐃𝐈𝐂𝐀𝐓𝐈𝐎𝐍
𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝟔 : 𝐀𝐍𝐓𝐈-𝐈𝐍𝐅𝐋𝐀𝐌𝐌𝐀𝐓𝐎𝐑𝐘 𝐓𝐇𝐄𝐀𝐔𝐏𝐄𝐔𝐓𝐈𝐂 𝐌𝐀𝐑𝐊𝐄𝐓, 𝐁𝐘 𝐑𝐄𝐆𝐈𝐎𝐍
𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝟕 : 𝐂𝐎𝐌𝐏𝐀𝐍𝐘 𝐏𝐑𝐎𝐅𝐈𝐋𝐄𝐒
𝐋𝐈𝐒𝐓 𝐎𝐅 𝐓𝐀𝐁𝐋𝐄𝐒
𝐋𝐈𝐒𝐓 𝐎𝐅 𝐅𝐈𝐆𝐔𝐑𝐄𝐒 ...... 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐞

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐑𝐞𝐯𝐢𝐞𝐰

The global anti-inflammatory therapeutic market is expected to witness a steady growth in the future. The market has drawn the interest of the healthcare industry, owing to increase in chronic & lifestyle-related diseases, rise in geriatric population, and increase in prevalence of chronic diseases. In addition, rise in R&D investments made by the government in the healthcare sector propels the growth of the market. However, lack of awareness, patent expires, side effects, and stringent regulations for anti-inflammatory drugs usage projected to hinder the market growth. On the contrary, rise in an adoption of anti-inflammatory drugs and developing biosimilar drugs are expected to offer remunerative opportunities for the expansion of the anti-inflammatory therapeutic market. In addition, increase in product approval is expected to boost the market growth in the near future.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view of providing business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.

We have professional corporate relations with various companies, and this helps us dig out market data that helps us generate accurate research data tables and confirms the utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high-quality data and help clients in every way possible to achieve success. Each and every piece of data presented in the reports published by us is extracted through primary interviews with top officials from leading companies in the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other